Irregular coarse vessel subtypes and the biopsy-to-EUS interval differentially predict the direction of endoscopic ultrasonography misjudgment in early gastric cancer

Background: Endoscopic ultrasonography (EUS) is widely used for accuracy for depth assessment of early gastric cancer (EGC). Irregular coarse vessels (ICV) on magnifying endoscopy with narrow-band imaging (ME-NBI) have been suggested as a potential endoscopic sign of submucosal invasion. However, whether their significance varies by relationship to prior biopsy sites, and whether the biopsy-to-EUS interval modulates this association, has not been systematically studied. This study aimed to evaluate factors independently associated with EUS overestimation and underestimation in EGC, focusing on the differential roles of non-biopsy-derived versus biopsy-derived irregular coarse vessels and the modulating effect of the biopsy-to-EUS interval on staging accuracy. Methods: This single-center retrospective study included 575 patients with EGC who underwent ME-NBI and EUS before endoscopic submucosal dissection. ICV were classified as non-biopsy-derived (NC-ICV) or biopsy-derived (BC-ICV) according to their relationship with prior biopsy sites. Multinomial logistic regression, interaction, stratified, and sensitivity analyses were performed. Results: EUS findings agreed with histopathology in 397 patients (69.0%), with underestimation in 54 (9.4%) and overestimation in 124 (21.6%). NC-ICV was independently associated with underestimation (OR 8.12) and BC-ICV with overestimation (OR 8.53). Poorly differentiated histology was an independent risk factor for underestimation (OR 3.21), whereas junior endoscopists were independently associated with overestimation (OR 1.67). In interaction analysis, the overestimation risk of BC-ICV was modulated by the biopsy-to-EUS interval, being strongest at <14 days (OR 43.26) and diminishing with longer intervals, whereas NC-ICV consistently predicted underestimation across all intervals, most pronounced beyond 20 days (OR 15.23). Sensitivity analysis confirmed the robustness of these findings. Conclusions: ICV subtype and the biopsy-to-EUS interval are independently associated with the direction of EUS misjudgment in EGC. These findings support deferring EUS to at least 3 weeks after biopsy when feasible.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11318796/v1
Primary Topic
Gastric Cancer Management and Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Irregular coarse vessel subtypes and the biopsy-to-EUS interval differentially predict the direction of endoscopic ultrasonography misjudgment in early gastric cancer

Limian Er, Nana An, Juntao Lu, Honghai Guo et al.
Research Square
Gastric Cancer Management and Outcomes
preprint

Irregular coarse vessel subtypes and the biopsy-to-EUS interval differentially predict the direction of endoscopic ultrasonography misjudgment in early gastric cancer

Limian Er, Nana An, Juntao Lu, Honghai Guo, Lei Zhang, Xiuli Zheng
preprint en

Abstract

Background: Endoscopic ultrasonography (EUS) is widely used for accuracy for depth assessment of early gastric cancer (EGC). Irregular coarse vessels (ICV) on magnifying endoscopy with narrow-band imaging (ME-NBI) have been suggested as a potential endoscopic sign of submucosal invasion. However, whether their significance varies by relationship to prior biopsy sites, and whether the biopsy-to-EUS interval modulates this association, has not been systematically studied. This study aimed to evaluate factors independently associated with EUS overestimation and underestimation in EGC, focusing on the differential roles of non-biopsy-derived versus biopsy-derived irregular coarse vessels and the modulating effect of the biopsy-to-EUS interval on staging accuracy. Methods: This single-center retrospective study included 575 patients with EGC who underwent ME-NBI and EUS before endoscopic submucosal dissection. ICV were classified as non-biopsy-derived (NC-ICV) or biopsy-derived (BC-ICV) according to their relationship with prior biopsy sites. Multinomial logistic regression, interaction, stratified, and sensitivity analyses were performed. Results: EUS findings agreed with histopathology in 397 patients (69.0%), with underestimation in 54 (9.4%) and overestimation in 124 (21.6%). NC-ICV was independently associated with underestimation (OR 8.12) and BC-ICV with overestimation (OR 8.53). Poorly differentiated histology was an independent risk factor for underestimation (OR 3.21), whereas junior endoscopists were independently associated with overestimation (OR 1.67). In interaction analysis, the overestimation risk of BC-ICV was modulated by the biopsy-to-EUS interval, being strongest at <14 days (OR 43.26) and diminishing with longer intervals, whereas NC-ICV consistently predicted underestimation across all intervals, most pronounced beyond 20 days (OR 15.23). Sensitivity analysis confirmed the robustness of these findings. Conclusions: ICV subtype and the biopsy-to-EUS interval are independently associated with the direction of EUS misjudgment in EGC. These findings support deferring EUS to at least 3 weeks after biopsy when feasible.

Research Square
Fourth Hospital of Hebei Medical University (CN)
Good health and well-being
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon